BioSpace News Archive

Business

TxCell Shares Surge After Sangamo Therapeutics Announces it Will Acquire the French Company

Shares of France’s TxCell S.A. have skyrocketed about 150 percent this morning after Sangamo Therapeutics announced it was acquiring a majority stake in the company for €72 million (about $82 million) in a cash deal.

July 23, 2018
·
2 min read
·
Alex Keown
Business

BeiGene Shows Off Strong Results from Checkpoint Inhibitor While Eying Potential Approval for BTK Inhibitor

BeiGene is starting off the week with a bang. Late Sunday the company announced positive preliminary topline results from its Phase II trial of tislelizumab, the company’s investigational checkpoint inhibitor for relapsed/refractory classical Hodgkin’s lymphoma (R/R cHL).

July 23, 2018
·
3 min read
·
Alex Keown
Policy

W. French Anderson, the ‘Father of Gene Therapy’ Released from Prison

After spending 14 years behind bars for sexually molesting a 10-year-old girl, famed geneticist W. French Anderson was shocked to see the leaps and bounds made by scientists in his field when he emerged from prison.

July 23, 2018
·
2 min read
·
Alex Keown
Deals

A Deep Dive into This Year’s Biotech IPOs

So far in 2018, it’s been a good year for biotech initial public offerings (IPOs). According to a Crunchbase News article, in the second quarter of this year alone, there were at least 16 U.S. venture-backed biotech and healthcare IPOs—compared to only 11 tech IPOs in the same period.

July 23, 2018
·
4 min read
·
Mark Terry
Business

New CEOs Named in BioSpace’s Biopharma Movers and Shakers for July 23

It’s been a busy week for biopharma companies to name a chief executive officer. Over the past week, multiple companies have selected individuals to hold the top spots and guide the growth strategies of their companies.

July 23, 2018
·
4 min read
·
Alex Keown
Policy

Human Longevity, Inc. Sues J. Craig Venter Institute Over Trade Secrets

La Jolla, California-based Human Longevity, Inc. (HLI) filed a lawsuit against the J. Craig Venter Institute (JCVI). Although Venter himself is at the center of the suit, he is not personally being sued.

July 23, 2018
·
3 min read
·
Mark Terry
Business

Anima Biotech Inks $1 Billion-Plus Deal with Eli Lilly

Anima Biotech, based in Bernardsville, New Jersey, inked a discovery and development deal with Eli Lilly and Co. that has the potential to exceed $1 billion.

July 23, 2018
·
2 min read
·
Mark Terry
Policy

Theranos Settles Investor Lawsuit for Undisclosed Sum

Battered and beleaguered biotech Theranos, Inc. has settled another civil case. This time the financially strapped company settled a lawsuit filed be investors who claimed they were defrauded by the company.

July 23, 2018
·
3 min read
·
Alex Keown
Drug Development

Optimism at the Start of the Alzheimer’s Association International Conference

Although the biopharma industry is churning out failure after failure of Alzheimer’s drugs, the start of the Alzheimer’s Association International Conference (AAIC) being held in Chicago this week is being met with optimism.

July 23, 2018
·
3 min read
·
Mark Terry
Business

GSK’s R&D Head Hal Barron Will Take Center Stage This Week With Program Review

Nearly four months after acquiring 100 percent control of its consumer health unit, GlaxoSmithKline Chairman Philip Hampton may be pushing for the business to become a standalone entity apart from its pharma and vaccines division, according to The Financial Times.

July 23, 2018
·
3 min read
·
Alex Keown